Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Non-Current Liabilities (2020 - 2025)

BioAtla's Total Non-Current Liabilities history spans 6 years, with the latest figure at $46.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 35.39% year-over-year to $46.5 million; the TTM value through Dec 2025 reached $46.5 million, up 35.39%, while the annual FY2025 figure was $46.5 million, 35.39% up from the prior year.
  • Total Non-Current Liabilities reached $46.5 million in Q4 2025 per BCAB's latest filing, up from $42.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $46.5 million in Q4 2025 to a low of $17.5 million in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $28.1 million, with a median of $26.7 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 50.55% in 2024, then surged 119.91% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $23.8 million in 2021, then rose by 7.55% to $25.6 million in 2022, then increased by 14.02% to $29.2 million in 2023, then rose by 17.7% to $34.3 million in 2024, then surged by 35.39% to $46.5 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Total Non-Current Liabilities are $46.5 million (Q4 2025), $42.8 million (Q3 2025), and $24.1 million (Q2 2025).